Literature DB >> 7957559

Activation of 70-kDa S6 kinase, induced by the cytokines interleukin-3 and erythropoietin and inhibited by rapamycin, is not an absolute requirement for cell proliferation.

V Calvo1, M Wood, C Gjertson, T Vik, B E Bierer.   

Abstract

The cytokines interleukin (IL)-3 and erythropoietin (EPO) are critical regulators of the proliferation and differentiation of cells of the hematopoietic system, but their intracellular mechanisms of action are not fully understood. Binding of IL-3 to the IL-3 receptor (IL-3R) and binding of EPO to the EPOR both induce changes in intracellular tyrosine and serine/threonine phosphorylation; the phosphorylation of a number of polypeptides appears to be a shared response upon cytokine stimulation. We have previously shown that binding of IL-2 to the IL-2R activates the 70-kDa (p70) S6 kinase, a serine/threonine kinase whose activity is regulated by serine/threonine phosphorylation; the immunosuppressant rapamycin inhibits IL-2-dependent proliferation and IL-2-triggered activation of p70 S6 kinase. We, therefore, sought to examine whether induction of p70 S6 kinase activity is a conserved response upon cytokine triggering, and whether this activity is essential for cell proliferation. Proliferation of the IL-3-dependent pro-B cell line Ba/F3 transfected with the EPOR (Ba/F3-EPOR) can be supported by either IL-3 or EPO. In this cell line, both IL-3 and EPO induced p70 S6 kinase activity; rapamycin inhibited both the IL-3 and EPO-induced activation of the 70-kDa S6 kinase as well as cellular proliferation. Thus, p70 S6 kinase activation appears to be a common intermediate triggered by the stimulation of IL-3, EPO, and IL-2 receptors. The Friend spleen focus-forming virus gp55 renders the EPOR constitutively active, and confers growth factor independence on cells expressing EPOR. Ba/F3-EPOR cotransfected with gp55 (Ba/F3-EpoRgp55) and the erythroleukemia cell line MEL, which also expresses both the EPOR and gp55, were analyzed. Rapamycin inhibited the activation of p70 S6 kinase in both cell lines. However, rapamycin inhibited proliferation of Ba/F3-EpoRgp55 but not of MEL cells despite inhibition of p70 S6 kinase activity in both cells. Thus, p70 S6 kinase activation is not an absolute requirement for cell proliferation. These results are discussed in relation to the role of the activation of the 70-kDa S6 kinase activation pathway in the regulation of cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7957559     DOI: 10.1002/eji.1830241115

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  Cell cycle progression and proliferation despite 4BP-1 dephosphorylation.

Authors:  S O Marx; A R Marks
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Hypersensitivity to rapamycin of BJAB B lymphoblastoid cells.

Authors:  J E Kay; M C Smith; V Frost; G Y Morgan
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

3.  TOR controls translation initiation and early G1 progression in yeast.

Authors:  N C Barbet; U Schneider; S B Helliwell; I Stansfield; M F Tuite; M N Hall
Journal:  Mol Biol Cell       Date:  1996-01       Impact factor: 4.138

4.  Rapamycin (sirolimus) inhibits proliferating cell nuclear antigen expression and blocks cell cycle in the G1 phase in human keratinocyte stem cells.

Authors:  A F Javier; Z Bata-Csorgo; C N Ellis; S Kang; J J Voorhees; K D Cooper
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

5.  Rapamycin resistance tied to defective regulation of p27Kip1.

Authors:  Y Luo; S O Marx; H Kiyokawa; A Koff; J Massagué; A R Marks
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

6.  A regulatory role for cAMP in phosphatidylinositol 3-kinase/p70 ribosomal S6 kinase-mediated DNA synthesis in platelet-derived-growth-factor-stimulated bovine airway smooth-muscle cells.

Authors:  P H Scott; C M Belham; J al-Hafidh; E R Chilvers; A J Peacock; G W Gould; R Plevin
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

7.  Molecular crosstalk between p70S6k and MAPK cell signaling pathways.

Authors:  Jason A Lehman; Julian Gomez-Cambronero
Journal:  Biochem Biophys Res Commun       Date:  2002-04-26       Impact factor: 3.575

8.  Ribosomal p70S6K basal activity increases upon induction of differentiation of myelomonocytic leukemic cell lines HL60, AML14 and MPD.

Authors:  Julian Gomez-Cambronero; Tricia Frye; Michael Baumann
Journal:  Leuk Res       Date:  2004-07       Impact factor: 3.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.